Abiopharma

News list

Anand Bhaskar 🟢 acquired 30.0K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $18.83 Transaction Date: Jan 08, 2026 | Filing ID: 000003

Full text

News bot Jan. 12, 2026, 9:03 p.m.
🔍 Anand Bhaskar (Executive)

Company: Summit Therapeutics Inc. (SMMT)

Report Date: 2026-01-08
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 30,000
Detailed Transactions and Holdings:
- Acquired 30,000 shares of Stock Option (right to buy) at $18.83 per share (Derivative)
  Date: 2026-01-08 | Code: A | Expires: 2036-01-08 | equity_swap_involved: 0 | shares_owned_after: 30,000.00 | transaction_form_type: 4 | Footnotes: F2, F1
Footnotes:
- F1: The option was granted on January 8, 2026. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on January 8, 2027.
- F2: Not applicable.